Kaletra 200 mg/1
Lopinavir and Ritonavir · TABLET, FILM COATED · AbbVie Inc.
No Recall History
Plain English
Kaletra is a tablet, film coated containing lopinavir and ritonavir at 200 mg/1, taken oral. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Kaletra
- Generic Name
- Lopinavir and Ritonavir
- NDC Code (Product)
0074-4014- Manufacturer
- AbbVie Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA021906
- Drug Class
- Cytochrome P450 3A Inhibitor [EPC]; Protease Inhibitor [EPC]
- Marketing Start
- 04/08/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Kaletra used for?
Kaletra contains Lopinavir and Ritonavir. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Kaletra a controlled substance?
Kaletra is not classified as a controlled substance by the DEA.
What is the generic name for Kaletra?
The generic name for Kaletra is Lopinavir and Ritonavir. There are 6 other brand versions of Lopinavir and Ritonavir.
What is the NDC code for Kaletra 200 mg/1?
The NDC (National Drug Code) for Kaletra 200 mg/1 is 0074-4014, listed by AbbVie Inc..